Innovations in Genetics Microgravity

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts trends across genetics microgravity research. Microgravity is a disruptive opportunity for various segments of the healthcare sector, including pharmaceuticals, biotechnology, nutrition, and material sciences. Genetics microgravity research provides companies and researchers the ability to accelerate discovery processes for new drugs and vaccines, and to develop new crystals and materials, thereby accelerating human genome and origin of diseases understanding. The potential scientific, technological, and commercial benefits of genetics microgravity research are significant, and they are expected to revolutionize traditional processing methods.The corresponding

Table of Contents

Innovations in Genetics MicrogravityRecent Advances Across Genetics MicrogravityNext Generation Microgravity Remote Controlled LabsInterrogating Immune System Status and Cancer Risk in AstronautsNanoLaze Gene Edited Induced Pluripotent Stem CellsSample to Sequence DNA Analysis Workflow in SpaceExperimental Studies and Industry InteractionsExperimental Studies Under MicrogravityIndustry Interactions

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.